BioCentury
ARTICLE | Company News

Takeda acquiring Paradigm

March 12, 2007 11:56 PM UTC

Takeda (Tokyo:4502) will acquire metabolic, neurology and cancer company Paradigm ( Cambridge, U.K.). Terms of the deal were not disclosed. Paradigm's PTD 634, a small molecule, oral gonadotropin-rele...